查詢結果分析
相關文獻
頁籤選單縮合
題 名 | The Benefit of Individualized Low-Dose hCG Support for High Responders in GnRHa-Triggered IVF/ICSI Cycles |
---|---|
作 者 | Huang, Chen-yu; Shieh, Miawh-lirng; Li, Hsin-yang; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 79:7 2016.07[民105.07] |
頁 次 | 頁387-393 |
分類號 | 417.125 |
關鍵詞 | Agonist trigger; High responders; Human chorionic gonadotropin; hCG; In vitro fertilization; IVF; Ovarian hyperstimulation syndrome; OHSS; |
語 文 | 英文(English) |
英文摘要 | Background: To assess the pregnancy outcome and ovarian hyperstimulation syndrome (OHSS) incidence in high responders receiving gonadotropin-releasing hormone agonist (GnRHa) trigger plus individualized support of low-dose human chorionic gonadotropin (hCG). Such support includes 500e1000 IU hCG given at trigger and, if serum estradiol (E2) dropped to below 800 pg/mL before the 6th day after oocyte retrieval, an additional rescue dose of 300 IU hCG. Methods: This was a retrospective study of potential high responders aged from 28 years to 40 years at a tertiary fertility center in Taiwan. By means of chart review, we assessed the pregnancy outcome and OHSS incidence in high responders receiving GnRHa trigger plus individualized low-dose hCG support. The main outcomes were measured by ongoing pregnancy rate and OHSS incidence (SPSS), in which statistical significance was determined by Chi-square test. Results: Moderate to severe OHSS did not develop in any patient receiving GnRHa trigger plus individualized low-dose hCG support. In fact, a satisfactory ongoing pregnancy rate (46.9%) was noted in patients receiving GnRHa trigger plus individualized low-dose hCG support. Conclusion: Our study suggested that GnRHa trigger combined with individualized low-dose hCG support appears to be a safe approach with a satisfactory pregnancy outcome. |
本系統中英文摘要資訊取自各篇刊載內容。